Condition (MeSH)
Paratyphoid Fever
ClinicalTrials.gov lists 9 trials for Paratyphoid Fever or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
9 of the 9 trials are tagged with Paratyphoid Fever itself; the rest are tagged with a narrower condition beneath it.
When did Paratyphoid Fever trials start? (5)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2022 | 2 |
| 2014 | 2 |
| 2006 | 1 |
| 2003 | 1 |
| 2001 | 3 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 9 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Paratyphoid Fever trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 4 | 4 |
| Not applicable | 2 |
| Observational | 1 |
How many Paratyphoid Fever trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 8 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Paratyphoid Fever trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| GlaxoSmithKline | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Which publications cover Paratyphoid Fever? (12)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Genetic Susceptibility to Enteric Fever in Experimentally Challenged Human Volunteers. | Infection and immunity | 2022 | Yes |
| Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model. | PLoS neglected tropical diseases | 2020 | Yes |
| Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model. | PLoS neglected tropical diseases | 2019 | Yes |
| MAIT cell clonal expansion and TCR repertoire shaping in human volunteers challenged with Salmonella Paratyphi A. | Nature communications | 2018 | Yes |
| Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2017 | Yes |
Showing 5 of 12 publications.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Paratyphoid fever | 443227 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Paratyphoid fever | 443227 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.